Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LHCGR anticorps (N-Term)

LHCGR Reactivité: Humain IF, FACS, IHC Hôte: Souris Monoclonal LHCGR-1417 unconjugated
N° du produit ABIN6165116
  • Antigène Voir toutes LHCGR Anticorps
    LHCGR (Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR))
    Épitope
    • 20
    • 15
    • 6
    • 6
    • 6
    • 5
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term
    Reactivité
    • 65
    • 32
    • 24
    • 6
    • 6
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 44
    • 25
    • 1
    Souris
    Clonalité
    • 45
    • 25
    Monoclonal
    Conjugué
    • 29
    • 5
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp LHCGR est non-conjugé
    Application
    • 48
    • 30
    • 26
    • 20
    • 14
    • 13
    • 13
    • 9
    • 3
    • 3
    • 2
    • 1
    • 1
    Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (IHC)
    Fonction
    Mouse Monoclonal anti-Luteinizing Hormone / Choriogonadotropin Receptor (LHCGR/1417), Purified, with BSA
    Attributs du produit
    This antibody recognizes a protein of 78-85 kDa, which is identified as luteinizing hormone/choriogonadotropin receptor. Luteinizing hormone plays a role in spermatogenesis and ovulation by stimulating the testes and ovaries to produce steroids. Choriogonadotropin production in the placenta maintains estrogen and progesterone levels during the first trimester of pregnancy. Ovaries and testes abundantly express luteinizing hormone/choriogonadotropin receptor (LHCGR) as a seven transmembrane, G protein-coupled receptor glycoprotein. LHCGR influences the protective effect of pregnancy and Gonadotropin against breast cancer. The expression of LHCGR on breast carcinoma correlates in part to the degree of tumor differentiation. LHCGR -positive breast tumors occur more frequently in tumors with greater cell differentiation in premenopausal women. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.
    Purification
    Purified
    Immunogène
    Recombinant N-terminal fragment of human LHCGR (exact sequence is proprietary)
    Clone
    LHCGR-1417
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product LHCGR Anticorps primaire
  • Indications d'application
    Immunohistology (formalin) 0.5-1 μg/mL
    • Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 min
    • Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Immunofluorescence 1-2 μg/mL
    • Optimal dilution for a specific application should be determined by user
    Commentaires

    HepG2 or Jurkat cells. Ovarian Carcinoma

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    200 μg/mL
    Buffer
    PBS/0.05 % BSA/0.05 % azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Antigène
    LHCGR (Luteinizing Hormone/Choriogonadotropin Receptor (LHCGR))
    Autre désignation
    Luteinizing Hormone / Choriogonadotropin Receptor (LHCGR Produits)
    Synonymes
    anticorps HHG, anticorps LCGR, anticorps LGR2, anticorps LH/CG-R, anticorps LH/CGR, anticorps LHR, anticorps LHRHR, anticorps LSH-R, anticorps ULG5, anticorps Gpcr19-rs1, anticorps LH-R, anticorps Lhr, anticorps LSHR, anticorps lhr, anticorps GTHR-II, anticorps zfGTHR-II, anticorps LHCGR, anticorps LOC100222883, anticorps lh-r, anticorps LOC100305044, anticorps luteinizing hormone/choriogonadotropin receptor, anticorps luteinizing hormone/choriogonadotropin receptor L homeolog, anticorps luteinizing hormone receptor, anticorps LHCGR, anticorps Lhcgr, anticorps lhcgr, anticorps lhcgr.L, anticorps lhr, anticorps LOC100305044
    Poids moléculaire
    78-85 kDa
    ID gène
    3973, 468490
    UniProt
    P22888
    Pathways
    Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, cAMP Metabolic Process, Glycosaminoglycan Metabolic Process, Regulation of Carbohydrate Metabolic Process, Autophagy, Negative Regulation of intrinsic apoptotic Signaling
Vous êtes ici:
Support technique